| Name | Title | Contact Details |
|---|
Partnet is a trusted software and technology leader for the US Government. With over 20 years of experience , Partnet is the company our customers turn to time and again. As the leading provider of comprehensive, flexible, and targeted IT solutions, ...
Data-driven decisions for evidence-based interventions in middle school and high schools career and technical education. Gather student insights.
Advalent is an end-to-end solutions platform that empowers payers to innovate, automate, and administer their entire business through modern technology.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Dot Compliance is a company that provides a ready-to-use Quality Management Solution (QMS) powered by the Salesforce.com platform, specifically designed for the life science industry. Their cloud-based eQMS is compliant with FDA 21 CFR part 11 and buil...